3-((S)-1-(dimethylamino)ethyl)phenyl methyl-((R)-1-phenylpropan-2 yl)carbamate hydrogen succinate | 1247027-66-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-((S)-1-(dimethylamino)ethyl)phenyl methyl-((R)-1-phenylpropan-2 yl)carbamate hydrogen succinate
• 英文别名: butanedioic acid;[3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-methyl-N-[(2R)-1-phenylpropan-2-yl]carbamate
• CAS: 1247027-66-2
• 化学式: C₄H₆O₄*C₂₁H₂₈N₂O₂
• 分子量: 458.555
• InChiKey: OOTMZIJTQPBDEH-PPPUBMIESA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.31
• 重原子数：
  33
• 可旋转键数：
  10
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  107
• 氢给体数：
  2
• 氢受体数：
  7

反应信息

• 作为产物：
  描述：

  丁二酸 、 3-((S)-1-(dimethylamino)ethyl)phenyl methyl-((R)-1-phenylpropan-2 yl)carbamate 以to yield 3-((S)-1-(dimethylamino)ethyl)phenyl methyl-((R)-1-phenylpropan-2 yl)carbamate hydrogen succinate的产率得到3-((S)-1-(dimethylamino)ethyl)phenyl methyl-((R)-1-phenylpropan-2 yl)carbamate hydrogen succinate
  参考文献：
  名称：

  COMPOSITIONS OF CHOLINESTERASE INHIBITORS

  摘要：

  本发明涉及与3-((S)-1-(二甲氨基)乙基)苯甲基-((R)-1-苯基丙烷-2-基)氨基甲酸甲酯及其药学上可接受的盐形式，包括富马酸氢盐相关的合成方法和过程的组合物。本发明还涉及3-((S)-1-(二甲氨基)乙基)苯甲基-((R)-1-苯基丙烷-2-基)氨基甲酸甲酯的一种新型多形态，其特征是具有独特的X射线衍射图案和差示扫描量热分析（DSC）剖面，以及独特的晶体结构。

  公开号：

  US20100256229A1

文献信息

• [EN] COMPOSITIONS OF CHOLINESTERASE INHIBITORS<br/>[FR] COMPOSITIONS À BASE D'INHIBITEURS DE LA CHOLINESTÉRASE
  申请人：COLUCID PHARMACEUTICALS INC

  公开号：WO2010115124A2

  公开（公告）日：2010-10-07

  The present invention is directed to compositions, methods of use, and processes for the synthesis related to 3-((S)-l-(dimethylamino)ethyl)phenyl methyl-((R)- 1 -phenylpropan-2 yl)carbamate, and its pharmaceutically acceptable salt forms, including the hydrogen fumarate salt. The present invention also relates to a novel form polymorph of 3-((S)-l- (dimethylamino)ethyl)phenyl methyl-((R)- 1 -phenylpropan-2 yl)carbamate, characterized by a unique X-ray diffraction pattern and Differential Scanning Calorimetry profile, as well a unique crystalline structure.
• COMPOSITIONS OF CHOLINESTERASE INHIBITORS
  申请人：Du Shoucheng

  公开号：US20100256229A1

  公开（公告）日：2010-10-07

  The present invention is directed to compositions, methods of use, and processes for the synthesis related to 3-((S)-1-(dimethylamino)ethyl)phenyl methyl-((R)-1-phenylpropan-2 yl)carbamate, and its pharmaceutically acceptable salt forms, including the hydrogen fumarate salt. The present invention also relates to a novel form polymorph of 3-((S)-1-(dimethylamino)ethyl)phenylmethyl-((R)-1-phenylpropan-2 yl)carbamate, characterized by a unique X-ray diffraction pattern and Differential Scanning Calorimetry profile, as well a unique crystalline structure.

  本发明涉及与3-((S)-1-(二甲基氨基)乙基)苯基甲基-((R)-1-苯基丙烷-2基)氨基甲酸酯及其药用可接受盐形式相关的合成的组合物、使用方法和过程，包括富马酸盐。本发明还涉及3-((S)-1-(二甲基氨基)乙基)苯基甲基-((R)-1-苯基丙烷-2基)氨基甲酸酯的新型形态多晶形态，其具有独特的X射线衍射图案和差示扫描量热分析剖面，以及独特的晶体结构。